Digital Health Investors & VC Firms
1179 firms in this list, with a median first check of $500K. 292 of them lead rounds. Generated from verified public data and updated continuously.
Krillion Ventures
MiamiSeed–Series A
3 people
Cheyenne Ventures
WoodsideSeries A–Late Stage
4 people
Seed Healthcare
DoradoPre-Seed–Series A
12 people
Clarevia Ventures
MadisonSeed–Series A$250K – $2.5M
11 people
InHealth Ventures
LondonPre-Seed–Series A$500K – $3M
5 people
MedStartr Ventures
New YorkSeed–Series A
11 people
Prolog Ventures
ClaytonSeries A–Late Stage$250K – $1M
5 people
Amboy Street Ventures
VeniceSeed–Series A
7 people
Aura Ventures
SydneyPre-Seed–Series A$330K – $1.3M
4 people
Purple Ventures
BrnoPre-Seed–Series A$270K – $430K
4 people
3CC | Third Culture Capital
BostonPre-Seed–Series A$250K – $1M
6 people
Bonaventure Equity, LLC
RaleighPre-Seed–Series A
12 people
Cameron Ventures
Oklahoma CitySeed–Series A$250K – $2M
3 people
Figure 8 Investments
Western North CarolinaSeed–Series B$50K – $500K
3 people
Lang Sheng Investment Group Co. Ltd.
ShanghaiPre-Seed–Series B
9 people
Prospect Venture Partners
Menlo ParkSeed–Late Stage$3M – $5M
3 people
Chrysalis Ventures
LouisvilleSeries A–Late Stage$1M – $10M
5 people
DIA
CaryPre-Seed–Series A
8 people
Fortify Ventures
WashingtonPre-Seed–Seed$100K – $2M
5 people
Lemhi Ventures
JordanSeed–Late Stage$500K – $5M
5 people
Sugati Ventures
San RamonSeed–Series A
11 people
ALIVE Israel HealthTech Fund
SavyonSeed–Late Stage
10 people
Cressey & Company
ChicagoGrowth
13 people
Welltech Ventures
Tel AvivSeed–Series A
10 people
Related lists
Investors & VC Firms in United States (5050)Crypto & Web3 Investors & VC Firms (4688)Investors & VC Firms in Global (4044)SaaS Investors & VC Firms (3602)AI & Machine Learning Investors & VC Firms (3577)Fintech Investors & VC Firms (3506)Healthtech Investors & VC Firms (3208)Enterprise Software Investors & VC Firms (3098)Investors & VC Firms in Europe (2833)Consumer Investors & VC Firms (2381)
Data sourced from public filings and firms' own websites — see our methodology.


































































